Alzheimer’s drugs should be prescribed like statins to stave off dementia, one of Britain’s leading neuroscientists has said.

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

Philip Stevens, a 66 year old from Hampshire, has received £70,000 from his GP following a lawsuit after he was given the ...

Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Hearing loss is associated with a higher risk of developing Parkinson disease, although hearing aids may help reduce risk.

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Lice live their entire lives with a set of genes that in humans would indicate a late-stage degenerative disorder such as Parkinson's or Alzheimer's disease. How do lice tolerate this genome structure ...

Dr James Pickett, Head of Research at Alzheimer’s Society, warned commonly-prescribed drugs that treat conditions including ...

"The best medication for Parkinson's will come from Israel. It will be a hybrid medication, and the world's best hybrid ...